FitLife Brands, Inc. (FTLF) - Q2 2025 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended June 30, 2025. FitLife Brands, Inc. is a provider of nutritional supplements and wellness products operating under brands including NDS Nutrition, iSatori, MRC (Dr. Tobias, Maritime Naturals), and MusclePharm. The company operates as a single reportable segment. As of August 11, 2025, there were 9,391,072 shares of common stock outstanding.
Key Financial Metrics
| Metric | Q2 2025 (3 Months) | Q2 2024 (3 Months) | YTD 2025 (6 Months) | YTD 2024 (6 Months) |
|---|---|---|---|---|
| Revenue | $16.13 million | $16.93 million | $32.06 million | $33.48 million |
| Gross Profit | $6.90 million | $7.58 million | $13.78 million | $14.87 million |
| Gross Margin | 42.8% | 44.8% | 43.0% | 44.4% |
| Operating Income | $2.52 million | $3.68 million | $5.48 million | $7.06 million |
| Net Income | $1.75 million | $2.63 million | $3.77 million | $4.79 million |
| Diluted EPS | $0.18 | $0.27 | $0.38 | $0.49 |
| Operating Cash Flow (YTD) | $3.52 million (vs. $6.61 million YTD 2024) | |||
| Cash & Equivalents (End of Period) | $1.53 million | |||
| Total Debt (Term Loans) | $10.88 million (Outstanding principal) |
Material Changes vs. Prior Period
- Revenue Decline: Q2 revenue decreased 5% year-over-year, driven primarily by a 16% decline in MRC revenue (due to reduced Amazon traffic) and a 4% decline in MusclePharm revenue. Legacy FitLife revenue increased 7%.
- Margin Compression: Gross margin decreased to 42.8% from 44.8% due to product mix shifts, promotional investments in MusclePharm, and tariff impacts on skincare products sold in Canada.
- Increased M&A Expenses: Merger and acquisition-related expenses surged to $0.70 million in Q2 (from $0.02 million in Q2 2024) due to transaction costs associated with the Irwin Naturals acquisition.
- Working Capital: Positive working capital increased to $9.21 million from $6.83 million at year-end 2024, supported by operating cash flows.
Outlook, Risks, and Subsequent Events
- Irwin Naturals Acquisition: Subsequent to the quarter end (August 8, 2025), the company acquired substantially all assets of Irwin Naturals for approximately $42.5 million. This was funded by a new $40.6 million term loan, a $10 million revolving credit line, and existing cash.
- Debt Restructuring: The new credit agreement refinanced all existing debt. The new term loan matures in August 2030 with interest rates based on SOFR plus a margin of 2.50% to 3.00%.
- Stock Split: A 2-for-1 stock split was effected on February 7, 2025. All share data in this report is retroactively adjusted.
- Risks: The company faces risks related to foreign currency fluctuations (primarily CAD), reliance on key customers (GNC represented 22% of Q2 revenue), and the ability to maintain debt covenants (Fixed Charge Coverage Ratio and Debt-to-EBITDA) under the new credit facility.
Investor Verification Checklist
- Irwin Integration: Verify the timeline for integrating Irwin Naturals and the expected impact on revenue and EBITDA in Q3 and Q4 2025.
- Debt Covenants: Confirm compliance with the new Senior Funded Debt to EBITDA ratio (max 2.75x initially) and Fixed Charge Coverage Ratio (min 1.25x) under the August 2025 credit agreement.
- MRC Recovery: Assess management's strategy to reverse the 16% revenue decline in the MRC portfolio, specifically regarding Amazon traffic and tariff mitigation.
- Cash Position: Monitor cash burn post-acquisition, as cash and equivalents dropped to $1.53 million prior to the new debt financing.
- Legacy FitLife Growth: Validate the sustainability of the 7% revenue growth in Legacy FitLife following the resolution of the GNC commercial dispute in early 2025.